Week In Review: VectorBuilder Raises $57 Million For Gene Therapy Delivery CDMO
Chicago-based VectorBuilder, a gene therapy delivery CDMO, raised $57 million in a Series C round from China investors.
Source: seekingalpha.com
Stay updated with breaking news from Anlong Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Chicago-based VectorBuilder, a gene therapy delivery CDMO, raised $57 million in a Series C round from China investors.